 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a Bullish indicator signaling SGEN's price could rise from here. Traders may explore going long the stock or buying call options...

Seagen (SGEN, $215.94) Moving Average Convergence Divergence (MACD) Histogram turned positive on December 5, 2023

FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV (enfortumab vedotin-ejfv) with KEYTRUDA (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer...

FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV (enfortumab vedotin-ejfv) with KEYTRUDA (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer

Seagen Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE:4503) today announced that on November 30, 2023 the U.S. Food and Drug Administration (FDA) accepted for priority review a supplemental...

Investors in Seagen Inc (SGEN) saw new options become available today, for the January 2024 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGEN options...

Interesting SGEN Put And Call Options For January 2024

Seagen (SGEN, $214.16) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 28, 2023

Pfizer CFO reiterates Seagen closing expected later this year, early next year...

Pfizer CFO reiterates Seagen closing expected later this year, early next year

This price move could indicate a change in the trend, and may be a buy signal for investors...

Seagen (SGEN, $214.45) price moved above its 50-day Moving Average on November 24, 2023

Seagen (SGEN, $214.17) price moved above its 50-day Moving Average on November 21, 2023

Investors in Seagen Inc (SGEN) saw new options begin trading today, for the January 2024 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SGEN options chain...

SGEN January 2024 Options Begin Trading

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Seagen Inc (SGEN) was identified as having a larger market cap than the smaller end of the S&P 500, for...

Seagen Larger Than S&P 500 Component Ford Motor

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Watchers	4,388
52-Wk Low	$117.09
52-Wk High	$217.51

Market Cap	$40.21B
Volume (M)	1.42M
52-Wk High	$217.51
52-Wk Low	$117.09

SGEN Seagen Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community